Proteomic-Based Discovery of Predictive Biomarkers for Drug Therapy Response and Personalized Medicine in Chronic Immune Thrombocytopenia.

Samira GilanchiMohammad FaranoushMahyar DaskarehFatemeh Sadat SadjjadiHakimeh Zali Ali Reza Ghassempour Mostafa Rezaei Tavirani

Published in: BioMed research international (2023)

. Our results indicate that plasma proteins (APOA1, GC, and TF) can be suitable biomarkers for the prognosis of the response to drug therapy in ITP patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
small molecule
drug induced
high throughput
emergency department
adverse drug
high resolution
electronic health record